Table 1. Bronchoalveolar Lavage Patient Cohort.
Group | Subject # | Age | Ethnicity | Gender | Smoking history | FEV1 (%pred) | FEV1/FVC | Medications | Approach | Current Smoker |
HS | 1 | 53 | C1 | F | 20 | 98 | 0.77 | N | Oral | Yes |
2 | 45 | C1 | F | 16 | 103 | 0.80 | N | Nasal | Yes | |
3 | 45 | C1 | M | 20 | 114 | 0.93 | N | Nasal | Yes | |
4 | 49 | AI/NA2 | F | 40 | 102 | 0.76 | N | Nasal | Yes | |
5 | 50 | AA3 | M | 15 | 99 | 0.77 | N | Nasal | Yes | |
6 | 47 | C1 | F | 39 | 96 | 0.76 | N | Nasal | Yes | |
7 | 66 | C1 | M | 32 | 110 | 0.80 | N | Nasal | No | |
CS | 1 | 54 | C1 | M | 120 | 79 | 0.63 | ICS4/LAB5 | Nasal | No |
2 | 62 | C1 | M | 68 | 78 | 0.68 | N | Nasal | Yes | |
3 | 40 | AA3 | M | 25 | 79 | 0.67 | N | Oral | Yes | |
4 | 60 | C1 | M | 41 | 25 | 0.41 | ICS4/LAB5 | Oral | No | |
NS | 1 | 48 | C1 | F | 0 | 105 | 0.86 | N | Nasal | No |
2 | 78 | C1 | F | 0 | 83 | 0.77 | N | Nasal | No | |
3 | 58 | C1 | F | 0 | 142 | 0.80 | N | Nasal | No |
= Caucasian;
= American Indian/Native American;
= African American;
= Inhaled Corticosteroids;
= Long Acting Beta-Agonists.